Science Explorer Back to mapMap
Discussion
Company · Lund · Sweden

BioInvent (Sweden)

bioinvent.comROR OpenAlex
Research works
65
▼ 45% vs 2018-21
Citations
1.8k
27.4 per fractional work
Top-10% rate
10.3%
all institutions 10.0%
Open access
40%
world 40%
International
42%
world 18%
BioInvent (Sweden)

Not ranked overall: BioInvent (Sweden) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does BioInvent (Sweden) work in?

In all years, 54% of research at BioInvent (Sweden) is in Life Sciences, 41% in Health Sciences. Its largest fields are Medicine (41%), Biochemistry, Genetics and Molecular Biology (28%), Immunology and Microbiology (26%). It does 3.0× the world's share of Life Sciences.

Life Sciences: 35 fractional works · 54.2% of its workBiochemistry, Genetics and Molecular Biology: 18 fractional works · 28.0% of its workMolecular Biology: 16 fractional works · 24.9% of its workGenetics: 1 fractional works · 1.3% of its workBiotechnology: 1 fractional works · 1.2% of its workCancer Research: 0 fractional works · 0.4% of its workCell Biology: 0 fractional works · 0.2% of its workImmunology and Microbiology: 17 fractional works · 25.6% of its workImmunology: 16 fractional works · 25.3% of its workParasitology: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 0 fractional works · 0.4% of its workInsect Science: 0 fractional works · 0.4% of its workNeuroscience: 0 fractional works · 0.1% of its workHealth Sciences: 27 fractional works · 40.9% of its workMedicine: 27 fractional works · 40.8% of its workRadiology, Nuclear Medicine and Imaging: 12 fractional works · 19.2% of its workOncology: 3 fractional works · 5.0% of its workHematology: 2 fractional works · 3.0% of its workGenetics: 2 fractional works · 2.4% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 1.8% of its workRheumatology: 1 fractional works · 1.6% of its workPulmonary and Respiratory Medicine: 1 fractional works · 1.5% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 0.9% of its workUrology: 0 fractional works · 0.8% of its workPathology and Forensic Medicine: 0 fractional works · 0.7% of its workImmunology and Allergy: 0 fractional works · 0.5% of its workInfectious Diseases: 0 fractional works · 0.5% of its workPhysiology: 0 fractional works · 0.5% of its workBiochemistry: 0 fractional works · 0.4% of its workEpidemiology: 0 fractional works · 0.4% of its workSurgery: 0 fractional works · 0.4% of its workReproductive Medicine: 0 fractional works · 0.3% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.3% of its workInternal Medicine: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.5% of its workNursing: 0 fractional works · 0.1% of its workPhysical Sciences: 3 fractional works · 4.9% of its workEngineering: 2 fractional works · 2.5% of its workBiomedical Engineering: 1 fractional works · 1.5% of its workBuilding and Construction: 0 fractional works · 0.5% of its workElectrical and Electronic Engineering: 0 fractional works · 0.5% of its workMaterials Science: 1 fractional works · 1.0% of its workBiomaterials: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.3% of its workChemistry: 1 fractional works · 1.0% of its workSpectroscopy: 0 fractional works · 0.7% of its workOrganic Chemistry: 0 fractional works · 0.3% of its workEnvironmental Science: 0 fractional works · 0.3% of its workEcology: 0 fractional works · 0.3% of its workComputer Science: 0 fractional works · 0.1% of its workALL ITS WORKBioInvent(Sweden)65fractional works, all years
Life Sciences54%Physical Sciences5%Health Sciences41%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 11 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1828.0%
    2. Immunology and Microbiology1725.6%
    3. Agricultural and Biological Sciences00.4%
    4. Neuroscience00.1%
    1. Medicine2740.8%
    2. Nursing00.1%
    1. Engineering22.5%
    2. Materials Science11.0%
    3. Chemistry11.0%
    4. Environmental Science00.3%
    5. Computer Science00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at BioInvent (Sweden)?

Ranked on the quality score, Björn Frendéus, Ingrid Teige and Linda Mårtensson lead among researchers whose main affiliation is BioInvent (Sweden).

  1. 1 Björn Frendéus Sweden · #440,033 worldwide 3.7k citations · 120 works
  2. 2 Ingrid Teige Sweden · #1,193,344 worldwide 2.2k citations · 94 works
  3. 3 Linda Mårtensson Sweden · #1,328,130 worldwide 1.2k citations · 79 works
  4. 4 Monika Semmrich Sweden · #1,852,937 worldwide 1.3k citations · 43 works
  5. 5 Mathilda Kovacek Sweden · #1,999,859 worldwide 263 citations · 15 works
  6. 6 Ulla‐Carin Tornberg Sweden · #2,295,500 worldwide 366 citations · 24 works
  7. 7 Steven Glazer Sweden · #2,962,341 worldwide 974 citations · 27 works
  8. 8 Petra Holmkvist Sweden · #2,973,145 worldwide 183 citations · 37 works
  9. 9 Mikael Mattsson Sweden · #3,385,454 worldwide 186 citations · 26 works
  10. 10 Andrés McAllister Sweden · #3,430,180 worldwide 698 citations · 86 works
All ranked researchers at BioInvent (Sweden)

What are the most cited papers from BioInvent (Sweden)?

The most cited paper from BioInvent (Sweden) is "Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies" (Frederick Arce Vargas et al., 2018), with 594 citations. Next come "Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries" (337) and "Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2–mediated heparin-binding EGF signaling in endothelial cells" (287).

Most cited papers
#PaperReleasedCitations
1 Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies Frederick Arce Vargas et al. · Cancer Cell Open access255 authors 22 Mar 2018 594
2 Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries Eskil Söderlind, Leif Strandberg, Pernilla Jirholt et al. · Nature Biotechnology Aug 2000 337
3 Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2–mediated heparin-binding EGF signaling in endothelial cells Katrin J. Svensson, Paulina Kucharzewska, Helena C. Christianson et al. · Proceedings of the National Academy of Sciences Open access 25 Jul 2011 287
4 Splenic Metabolic Activity Predicts Risk of Future Cardiovascular Events Hamed Emami, Parmanand Singh, Megan H. MacNabb et al. · JACC. Cardiovascular imaging Open access 7 Jan 2015 264
5 Recombinant Antibodies to an Oxidized Low-Density Lipoprotein Epitope Induce Rapid Regression of Atherosclerosis in Apobec-1−/−/Low-Density Lipoprotein Receptor−/−Mice Alexandru Șchiopu, Björn Frendéus, Bo Jansson et al. · Journal of the American College of Cardiology Open access Dec 2007 180
All 61 most cited papers, with filters and sorting

Which keywords describe research at BioInvent (Sweden)?

By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Cancer, Autoimmunity and Immune System.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glycosylation18▲ 129×3 topics
  2. Monoclonal Antibodies14▲ 150×2 topics
  3. Therapeutic Antibodies14▲ 167×2 topics
  4. Antibody Engineering12▲ 181×1 topic
  5. Fc Receptors12▲ 181×1 topic
  6. Cancer8▲ 8.6×14 topics
  7. Autoimmunity6▲ 46×4 topics
  8. Immune System6▲ 28×2 topics
  9. Glycans6▲ 110×1 topic
  10. Mucins6▲ 110×1 topic
  11. Foxp35▲ 105×1 topic
  12. TGF-ß5▲ 46×1 topic
  13. Inflammation5▲ 3.2×19 topics
  14. Dendritic Cells5▲ 62×2 topics
  15. Cancer Immunotherapy4▲ 49×2 topics
  16. Immunity4▲ 16×6 topics
  17. Innate Immunity3▲ 14×2 topics
  18. Antigen Presentation3▲ 48×2 topics
  19. NK Cell Recognition3▲ 45×1 topic
  20. Natural Killer Cells3▲ 45×1 topic
  21. Tumor Antigen3▲ 57×1 topic
  22. Vaccine Adjuvants3▲ 57×1 topic
  23. Immunotherapy2▲ 6.0×6 topics
  24. Biopharmaceuticals2▲ 55×2 topics
  25. Recombinant Proteins2▲ 70×2 topics
  26. Immune Response2▲ 5.8×8 topics
  27. Protein Aggregation2▲ 44×1 topic
  28. Stability2▲ 18×1 topic
  29. Atherosclerosis2▲ 9.2×4 topics
  30. Lymphoma2▲ 23×3 topics
  31. Rituximab2▲ 21×3 topics
  32. Tumor Regression2▲ 36×2 topics
  33. High-Throughput Analysis2▲ 68×1 topic
  34. Protein Microarrays2▲ 156×1 topic
  35. Regulatory T Cells2▲ 25×2 topics
  36. Therapeutic Targets2▲ 11×3 topics
  37. Adaptive Immunity2▲ 97×1 topic
  38. Cytokines2▲ 9.7×2 topics
  39. Leukemia2▲ 41×2 topics
  40. Oxidized LDL2▲ 97×1 topic

Which research topics does BioInvent (Sweden) publish most on?

By volume in 2022-now: Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers and CAR-T cell therapy research.

Monoclonal and Polyclona…1Monoclonal and Polyclonal Antibodies Research: 1 fractional worksImmunotherapy and Immune…1Immunotherapy and Immune Responses: 1 fractional worksCancer Immunotherapy and…0Cancer Immunotherapy and Biomarkers: 0 fractional worksCAR-T cell therapy research: 0 fractional worksHER2/EGFR in Cancer Research: 0 fractional worksGlycosylation and Glycop…0Glycosylation and Glycoproteins Research: 0 fractional worksT-cell and B-cell Immunology: 0 fractional worksImmune Cell Function and Interaction: 0 fractional worksVirus-based gene therapy research: 0 fractional worksCancer Research and Treatments: 0 fractional works
Radiology, Nuclear Medicine and ImagingImmunologyOncologyMolecular Biology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  2. 2 Immunotherapy and Immune Responses Immunology 1 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 0 works
  4. 4 CAR-T cell therapy research Oncology 0 works
  5. 5 HER2/EGFR in Cancer Research Oncology 0 works
  6. 6 Glycosylation and Glycoproteins Research Molecular Biology 0 works
  7. 7 T-cell and B-cell Immunology Immunology 0 works
  8. 8 Immune Cell Function and Interaction Immunology 0 works
  9. 9 Virus-based gene therapy research Genetics 0 works
  10. 10 Cancer Research and Treatments Biotechnology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available40.4%not open59.6%

World: 40% of research is openly available.

with international co-authors41.7%domestic only58.3%

World: 18% is written across borders.

How has BioInvent (Sweden)'s research output changed?

Output in 2022-2025 was 45% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is BioInvent (Sweden) as a percentage of every work published that year, 0.000013% in 2024.

still counting0.00020%0.00040%0.00060%BioInvent (Sweden)0.000030% in 20251990200020102020

Fractional works of BioInvent (Sweden) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Lund

All research institutions in Lund

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about BioInvent (Sweden). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.